What is the strategic rationale behind CVS Health acquiring Signify Health?

The acquisition of Signify Health is expected to enhance CVS Health's capabilities in the rapidly growing home health sector and its ability to manage value-based care arrangements. Signify Health's technology and provider network can support CVS Health's strategy to deliver more comprehensive, coordinated care, particularly in the home setting, which is becoming increasingly important in healthcare.

What is the total value of the transaction?

The transaction values Signify Health at approximately $8 billion, with each share of Signify Health common stock to be converted into the right to receive $30.50 in cash.

What are the key conditions for closing the acquisition?

Key conditions include obtaining approval from Signify Health's stockholders, the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act, the absence of any laws or orders prohibiting the merger, and the absence of any material adverse effect on Signify Health.

Are there any potential financial penalties if the deal does not close?

Yes, the Merger Agreement includes provisions for termination fees. CVS Health would be required to pay Signify Health $380 million if the agreement is terminated due to a failure to obtain antitrust approval. Signify Health would be required to pay CVS Health $228 million under certain circumstances, such as terminating the agreement to accept a superior proposal or if its Board changes its recommendation to stockholders.

CVS 8-K: Material Agreements

Summary

CVS Health Corporation (CVS) announced a significant strategic move through its subsidiary, CVS Pharmacy, Inc., entering into a Merger Agreement to acquire Signify Health, Inc. for $30.50 per share in cash. This acquisition, valued at approximately $8 billion, positions CVS Health to expand its capabilities in home healthcare services and technology. The deal is expected to enhance CVS Health's integrated healthcare offerings and provide a platform for growth in value-based care delivery. The transaction is subject to customary closing conditions, including Signify Health stockholder approval and antitrust clearance. The agreement includes provisions for potential termination fees for both parties under specific circumstances. A significant voting agreement has been secured from New Mountain Capital, which holds a substantial voting interest in Signify Health, to support the transaction. This acquisition marks a key step in CVS Health's strategy to evolve beyond traditional pharmacy services into a more comprehensive healthcare provider.

Key Highlights

1CVS Health, via subsidiary CVS Pharmacy, Inc., has entered into a definitive agreement to acquire Signify Health, Inc.
2The acquisition price is $30.50 per share in cash for all outstanding Signify Health common stock.
3Signify Health's Board of Directors has unanimously approved and recommended the transaction to its stockholders.
4The deal is expected to significantly expand CVS Health's presence in home health and value-based care.
5A voting agreement with New Mountain Capital, a major Signify Health stockholder, has been secured, representing approximately 59.4% of Signify Health's total voting power, to support the merger.
6The transaction is subject to customary closing conditions, including regulatory approvals (e.g., HSR Act) and stockholder approval.
7Specific termination fees are outlined, with CVS Health potentially paying $380 million if antitrust approval is not obtained, and Signify Health potentially paying $228 million under certain circumstances, including accepting a superior proposal.

CVS HEALTH Corp 8-K Report, Material Agreement (Sep 6, 2022)

Summary

Key Highlights

Frequently Asked Questions